Ikizler T Alp
of Nephrology, Vanderbilt University Medical Center, 1161 21st Avenue, South & Garland, S-3223 MCN, Nashville, TN 37232-2372 USA.
Adv Chronic Kidney Dis. 2004 Apr;11(2):162-71. doi: 10.1053/j.arrt.2004.01.008.
Cardiovascular disease (CVD) is the major cause of death in end-stage renal disease (ESRD) patients. Uremic malnutrition and chronic inflammation are important comorbid conditions, closely associated with CVD risk in ESRD patients. A pathophysiologic link between uremic malnutrition, chronic inflammation, and atherosclerosis has been proposed in this patient population. Uremic malnutrition can result from chronic inflammation and can accelerate the progression of cardiovascular disease. Chronic inflammation can also directly predispose ESRD patients to a proatherogenic state. Both uremic malnutrition and chronic inflammation are also associated with increased oxidative stress, a condition proposed as a unifying concept of CVD in uremia. Although a single common etiology has not been identified in this complex process, nutritional, anti-inflammatory, and antioxidant interventions can provide potential treatment options to improve the high mortality and morbidity in ESRD patients.
心血管疾病(CVD)是终末期肾病(ESRD)患者的主要死因。尿毒症营养不良和慢性炎症是重要的合并症,与ESRD患者的CVD风险密切相关。在这一患者群体中,已提出尿毒症营养不良、慢性炎症与动脉粥样硬化之间存在病理生理联系。尿毒症营养不良可由慢性炎症导致,并可加速心血管疾病的进展。慢性炎症也可直接使ESRD患者易处于促动脉粥样硬化状态。尿毒症营养不良和慢性炎症还均与氧化应激增加有关,氧化应激被认为是尿毒症中CVD的一个统一概念。尽管在这一复杂过程中尚未确定单一的共同病因,但营养、抗炎和抗氧化干预可为改善ESRD患者的高死亡率和高发病率提供潜在的治疗选择。